Home Coronavirus COVID-19 AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant February 7, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Lemus Clarifies: U.S. Alert Was Over Extortion, Not Kidnapping VIDEO: Cyclone Alvin Causes Severe Flooding Across State of Mexico Municipalities Fire in Drug Rehabilitation Center in Guanajuato Kills 12 Sheinbaum Concludes National Tour in Jalisco, Showcasing House-to-House Health Program Jalisco Expands Air Connectivity with Canada to Boost Tourism and Trade
